Shane CPA - Chemours Senior CFO
| 0HWG Stock | 21.47 0.29 1.33% |
CFO
Shane CPA is Senior CFO of Chemours Co
| Age | 43 |
| Address | 1007 Market Street, Wilmington, DE, United States, 19801 |
| Phone | 302 773 1000 |
| Web | https://www.chemours.com |
Chemours Management Efficiency
The company has return on total asset (ROA) of 0.0397 % which means that it generated a profit of $0.0397 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1102 %, meaning that it generated $0.1102 on every $100 dollars invested by stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Chemours' Non Currrent Assets Other are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 175.3 M in 2024, whereas Total Assets are likely to drop slightly above 7.5 B in 2024.Similar Executives
| Found 6 records | CFO Age | ||
| Thierry Philippe | Jacquet Metal Service | N/A | |
| James Nickolas | Martin Marietta Materials | 53 | |
| Patrick Obara | GoldMining | 68 | |
| James JD | Martin Marietta Materials | 53 | |
| Robert Halliday | Applied Materials | 70 | |
| Brice Hill | Applied Materials | 57 | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0397 |
Chemours Leadership Team
Elected by the shareholders, the Chemours' board of directors comprises two types of representatives: Chemours inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemours. The board's role is to monitor Chemours' management team and ensure that shareholders' interests are well served. Chemours' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemours' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan Lock, Senior Officer | ||
| Amber Wellman, Chief Officer | ||
| Kurt Bonner, Ma Relations | ||
| Kristine Wellman, General VP | ||
| Matthew Abbott, Interim Officer | ||
| Shane Hostetter, Senior CFO | ||
| Sameer Ralhan, VP CFO | ||
| Shane CPA, Senior CFO | ||
| Brandon Ontjes, Vice Relations | ||
| Camela Wisel, Chief VP | ||
| Denise Dignam, President Technologies | ||
| Mark Newman, President CEO | ||
| Aditya Beri, Interim Business | ||
| Edwin Sparks, Pres Solutions | ||
| Brian Shay, Interim Officer | ||
| Ron Charles, Senior People | ||
| Alisha Bellezza, Pres Solutions | ||
| Joseph Martinko, President Solutions | ||
| Susan Kelliher, VP People | ||
| Alvenia Scarborough, Senior Officer | ||
| Gerardo Calderon, President Materials |
Chemours Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemours a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0397 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 6.95 B | ||||
| Shares Outstanding | 171.08 M | ||||
| Shares Owned By Insiders | 0.72 % | ||||
| Shares Owned By Institutions | 82.93 % | ||||
| Price To Sales | 0.64 X | ||||
| Revenue | 6.03 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Chemours Stock Analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.